Biotechnology : are firms born great or can you build greatness?
Name
54040122-MIT.pdf
Description
Full printable version
Size
2.12 MB
Format
Adobe PDF
Checksum (MD5)
38ad23827f5f5a1a28a3c4320b0061c7
Author(s)
Yeyinmen, Ali, 1971-
Advisor(s)
Fiona Murray.
Date Issued
2003
Publisher
Massachusetts Institute of Technology
Abstract
The importance of "star scientists" in new biotechnology venture formation has been studied by many scholars. However, it is not clear to degree to which their involvement leads to a successful venture. This study examines the importance of the Scientific Advisory Board (SAB), management and venture capital firms during new biotechnology venture creation. In particular, this study has determined if MIT and MIT-Harvard licensed technology companies are able to attract SAB members from top institutions, Board of Directors and CEOs from top pharmaceutical and biotechnology companies as well as top-tier venture capital firms, compared to other biotechnology start-ups in Massachusetts. The results of the study confirm that MIT-Harvard licensed technology companies are able to attract top tier people and venture capital investment during an economic boom as well as the downturn, and this reinforces the proposition that firms are "born" great, rather then achieve greatness at least in terms of the constellation of people who join the firm.
Description
Thesis (S.M.M.O.T.)--Massachusetts Institute of Technology, Sloan School of Management, Management of Technology Program, 2003.
Includes bibliographical references (leaves 58-59).
Subjects
Management of Technology Program.
MIT Department
Management of Technology Program.
Sloan School of Management
Terms of Use
M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Persistent DSpace Link
